Pilomatrixoma (pilomatricoma, calcifying epithelioma) is a benign cutaneous tumor originating from hair follicle matrix cells and is the most common calcified superficial soft tissue lesion in children. It shows bimodal age distribution: first peak <10 years (most common), second peak 50-70 years. Most commonly involves head-neck (50%) and upper extremities (30%). Clinically presents as a firm, immobile, 0.5-3 cm dermal/subcutaneous nodule with possible bluish discoloration (tenting sign) of overlying skin. CTNNB1 gene (encoding β-catenin) mutations play a central role in pathogenesis. Ultrasonography is the primary diagnostic modality — calcification + acoustic shadowing combination is nearly pathognomonic in children.
Age Range
1-25
Peak Age
10
Gender
Female predominant
Prevalence
Uncommon
Pilomatrixoma originates from hair follicle matrix cells — normal hair matrix cells keratinize and die to form the hair shaft. Activating mutations in the CTNNB1 gene stabilize β-catenin protein → constitutive activation of Wnt/β-catenin signaling pathway → uncontrolled matrix cell proliferation. The tumor consists of two cellular components: (1) basaloid (viable) cells — actively proliferating, peripherally located; (2) shadow/ghost cells — cells that lost nuclei through keratinization, eosinophilic, centrally located. Over time, shadow cells develop dystrophic calcification — calcium phosphate crystals accumulate in cell cytoplasm. This calcification creates the most characteristic US finding: internal calcified areas producing posterior acoustic shadowing. Calcification degree increases with lesion age — minimal in early lesions, may be completely calcified in mature lesions. The peripheral hypoechoic halo consists of inflammatory granulation tissue and viable basaloid cells → target-like appearance: peripheral hypoechoic rim + central calcified hyperechoic area. This target appearance differs from neurofibroma target sign: in pilomatrixoma the central area is hyperechoic + shadowing (calcification), in neurofibroma the central area is hypoechoic (myxoid).
In children, a subcutaneous calcified nodule in head-neck or upper extremity with posterior acoustic shadowing is nearly pathognomonic for pilomatrixoma. Target-like appearance with peripheral hypoechoic halo (central calcified + peripheral cellular) strengthens the diagnosis. Calcification degree is directly proportional to lesion maturity.
On B-mode US, prominent calcification is seen within pilomatrixoma — hyperechoic foci or areas producing posterior acoustic shadowing. Calcification pattern is variable: (1) coarse calcifications — large hyperechoic masses with complete shadowing, (2) fine calcifications — small echogenic dots or lines with partial shadowing, (3) complete calcification — entire lesion hyperechoic + complete posterior shadowing ('stone-like'). Calcification increases with lesion age and maturity. In early lesions (<6 months), calcification may be minimal or absent — may appear as solid hypoechoic nodule only.
Report Sentence
Prominent calcifications with posterior acoustic shadowing within the subcutaneous lesion; consistent with pilomatrixoma.
In pilomatrixoma, peripheral hypoechoic halo + central calcified hyperechoic area creates 'target-like' appearance. The peripheral hypoechoic halo consists of viable basaloid cells and inflammatory granulation tissue — this component has low acoustic impedance due to cellular and vascular nature. The central calcified area represents dystrophic calcification of shadow cells. This two-component appearance is especially prominent in partially calcified (intermediate stage) lesions. In completely calcified lesions, the peripheral halo may disappear.
Report Sentence
Target-like appearance consisting of peripheral hypoechoic halo and central calcified hyperechoic area is seen; consistent with pilomatrixoma.
Color and power Doppler may show peripheral vascularity in pilomatrixoma — neovascularization in granulation tissue and viable basaloid cells of the peripheral hypoechoic halo. Internal vascularity is generally absent because the central calcified area is avascular. This peripheral vascularity pattern indicates active, growing lesions. In completely calcified mature lesions, both peripheral and internal vascularity are absent. Perilesional vascularity may increase with inflammation.
Report Sentence
Vascular signals are detected in the peripheral halo on Doppler; the central calcified area is avascular.
On US, pilomatrixoma is seen as a dermal/subcutaneous, firm (resistant to compression) nodule. The overlying skin is thin and taut — 'tenting sign': skin stretches like a tent over the lesion when the probe passes over it. This reflects the lesion's proximity to dermis and firm structure. Seen in 'sandwich' position between subcutaneous fat and dermis. Bluish skin discoloration cannot be evaluated on US but is an important clue in clinical-sonographic correlation.
Report Sentence
Skin stretching (tenting sign) over the firm subcutaneous nodule is observed.
On CT, pilomatrixoma appears as a well-defined, calcified subcutaneous nodule. Calcification pattern is variable: completely calcified (most common in mature lesions), peripheral rim calcification, or scattered internal calcifications. Peripheral enhancement on contrast CT may reflect viable basaloid cells and granulation tissue. CT is not the primary modality for pilomatrixoma diagnosis (US is sufficient) but may be useful in large or deep-seated lesions.
Report Sentence
A well-defined calcified subcutaneous nodule is seen; consistent with pilomatrixoma.
On MRI T2, pilomatrixoma shows heterogeneous signal: viable basaloid cells T2 hyperintense, fibrous component T2 hypointense, calcified areas T2 signal void. Signal loss from susceptibility effect of calcifications may be prominent on GRE. Low-intermediate T1 signal. Enhancement in peripheral component (viable cells). MRI is rarely needed for pilomatrixoma diagnosis — US and clinical are usually sufficient.
Report Sentence
Subcutaneous lesion showing heterogeneous T2 signal; calcified areas show signal void.
Criteria
Most common form. Solitary, small (<3 cm), partially or completely calcified.
Distinct Features
Peak in first decade in children. Excision curative, recurrence rare (<3%).
Criteria
>5 cm, rare. May cause cosmetic and functional issues.
Distinct Features
Usually mature, completely calcified. Slightly higher malignant transformation risk than classic but still very low.
Criteria
2+ lesions, may be associated with Gardner syndrome, myotonic dystrophy, or Turner syndrome.
Distinct Features
Syndrome association should be evaluated. APC gene mutation should be investigated in Gardner syndrome.
Distinguishing Feature
Epidermoid cyst is cystic — laminated pattern, posterior enhancement, avascular. Pilomatrixoma is solid, calcified, with posterior shadowing. No calcification in epidermoid cyst.
Distinguishing Feature
Dermatofibroma is hypoechoic solid nodule within dermis, no calcification, dimple sign positive, common in young women. Pilomatrixoma is subcutaneous, calcified, common in children.
Distinguishing Feature
Schwannoma is nerve-associated, tail sign, posterior enhancement, no calcification. Pilomatrixoma has no nerve association, calcified, posterior shadowing.
Urgency
routineManagement
surgicalBiopsy
Not NeededFollow-up
no-follow-upPilomatrixoma is benign with extremely rare malignant transformation (<1% — pilomatrix carcinoma). Preoperative diagnosis is confidently made with typical clinical and US findings (calcification + shadowing, head-neck location in child) without biopsy. Treatment is surgical — marginal excision is curative with low recurrence (<3%). Incomplete excision carries recurrence risk. In multiple pilomatrixoma, Gardner syndrome, myotonic dystrophy, and Turner syndrome should be investigated. Postoperative follow-up generally not needed.
Pilomatrixoma is a benign lesion and surgical excision is curative. Malignant pilomatrixoma (pilomatrix carcinoma) is extremely rare. Multiple pilomatrixomas may be associated with Gardner syndrome (APC gene mutation), myotonic dystrophy, or Rubinstein-Taybi syndrome. Recurrence rate after excision is low (2-3%).